Posted by Michael Wonder on 29 Mar 2024
Paladin Labs announces approval of Wakix (pitolisant hydrochloride tablets) for use in paediatric patients in Canada
28 March 2024 - Indication includes children ages 6 years and older and weighing at least 30 kg.
Paladin Labs today announced Health Canada's approval of Wakix (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness or cataplexy in paediatric patients aged 6 years and older and weighing at least 30 kg with narcolepsy.
